Currently out of the existing stock ratings of James Condulis, 30 are a BUY (93.75%), 2 are a HOLD (6.25%).
Analyst James Condulis, currently employed at STIFEL, has had 29.44% of price targets met with an average potential upside of 37.47%, reached in 102 days on average.
James Condulis has documented 61 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MIRM, Mirum Pharmaceuticals at 15-Oct-2026.
Analyst best performing recommendations are on MIRM (MIRUM PHARMACEUTICALS).
The best stock recommendation documented was for SLNO (SOLENO THERAPEUTICS) on 3/12/2025. The price target of $74 was fulfilled within 43 days with a profit of $27.3 (58.46%), with a performance score of 13.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Aug-2023
$100
$43.87 (78.16%)
$84
13 days ago
(05-Nov-2026)
3/4 (75%)
$36.4 (57.23%)
123
Buy Since 27-Mar-2014
$140
$83.87 (149.42%)
$140
30 days ago
(19-Oct-2026)
44/75 (58.67%)
$77.35 (123.46%)
818
Buy Since 08-Nov-2024
$113
$56.87 (101.32%)
$112
1 months 10 days ago
(08-Oct-2026)
4/11 (36.36%)
$50.99 (82.23%)
448
Buy Since 09-Dec-2022
$103
$46.87 (83.50%)
$97
3 months 5 days ago
(13-Aug-2026)
10/12 (83.33%)
$29.55 (40.23%)
312
Buy Since 20-Dec-2022
$112
$55.87 (99.54%)
$106
3 months 8 days ago
(10-Aug-2026)
6/9 (66.67%)
$34.51 (44.53%)
366
Which stock is James Condulis most bullish on?
What Year was the first public recommendation made by James Condulis?